Suppr超能文献

P2Y和P2Y受体介导犬猫血小板聚集:与人类血小板的比较

P2Y and P2Y Receptors Mediate Aggregation of Dog and Cat Platelets: A Comparison to Human Platelets.

作者信息

Sophocleous Reece A, Curtis Stephen J, Curtis Belinda L, Ooi Lezanne, Sluyter Ronald

机构信息

Molecular Horizons and School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2522, Australia.

Your Village Vet Balgownie, Balgownie, NSW 2519, Australia.

出版信息

Int J Mol Sci. 2025 Jan 30;26(3):1206. doi: 10.3390/ijms26031206.

Abstract

Thrombosis is one of the most prevalent and serious health issues amongst humans. A key component of thrombotic events is the activation and aggregation of platelets, of which the P2Y and P2Y receptors play a crucial role in this process. Despite a breadth of knowledge on thrombosis and its mechanisms and treatment in various disorders in humans, there is less of an understanding of the expression and exact role of these receptors in companion animals such as dogs and cats. Therefore, this study aimed to investigate P2Y and P2Y receptors on dog and cat platelets in platelet-rich plasma and compare them to human platelets. Immunoblotting revealed the presence of P2Y and P2Y receptor proteins on dog and cat platelets, although relative amounts of each receptor appeared to contrast those of human platelets, with increased amounts of P2Y compared to P2Y receptors in dogs and cats. Using a modified 384-well plate aggregation assay, designed for use with small volumes, the human P2Y and P2Y receptor agonists adenosine 5'-diphosphate and 2-methylthio-adenosine 5'-diphosphate caused aggregation of dog and cat platelets. This aggregation was near-completely inhibited by the selective P2Y antagonist ticagrelor. Aggregation of dog and cat platelets was partly inhibited by the human P2Y receptor antagonist MRS2179. The agonist and antagonist responses in dog and cat platelets were like those of human platelets. In contrast, the aggregation of dog platelets in the absence of added nucleotides was two-fold greater than that of cats and humans. This study indicates that platelets of cats and dogs possess functional P2Y and P2Y receptors that can be inhibited by human antagonists. The data presented suggest differing roles or responses of the platelet P2Y receptors in dogs and cats compared to humans but also highlight the potential of using currently available P2Y or P2Y antiplatelet drugs such as ticagrelor for the treatment of thrombosis in these companion animals.

摘要

血栓形成是人类中最普遍和严重的健康问题之一。血栓形成事件的一个关键组成部分是血小板的激活和聚集,其中P2Y和P2Y受体在这一过程中起着至关重要的作用。尽管对人类各种疾病中的血栓形成及其机制和治疗有广泛的了解,但对于这些受体在犬猫等伴侣动物中的表达和确切作用了解较少。因此,本研究旨在调查富血小板血浆中犬猫血小板上的P2Y和P2Y受体,并将它们与人类血小板进行比较。免疫印迹显示犬猫血小板上存在P2Y和P2Y受体蛋白,尽管每种受体的相对含量似乎与人类血小板不同,犬猫中P2Y受体的含量相对于P2Y受体有所增加。使用专为小体积设计的改良384孔板聚集试验,人类P2Y和P2Y受体激动剂5'-二磷酸腺苷和2-甲硫基-5'-二磷酸腺苷可引起犬猫血小板聚集。这种聚集几乎被选择性P2Y拮抗剂替格瑞洛完全抑制。犬猫血小板的聚集被人类P2Y受体拮抗剂MRS2179部分抑制。犬猫血小板的激动剂和拮抗剂反应与人类血小板相似。相比之下,在不添加核苷酸的情况下,犬血小板的聚集比猫和人类的聚集大两倍。本研究表明,猫和狗的血小板具有功能性P2Y和P2Y受体,可被人类拮抗剂抑制。所呈现的数据表明,与人类相比,犬猫血小板P2Y受体的作用或反应不同,但也突出了使用目前可用的P2Y或P2Y抗血小板药物如替格瑞洛治疗这些伴侣动物血栓形成的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb93/11818226/c88508ebdb82/ijms-26-01206-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验